Table of Content 1 Industrial Chain Overview 1.1 Cancer Targeted Therapy Industry 1.1.1 Overview 1.1.2 Characteristics of Cancer Targeted Therapy 1.2 Upstream 1.2.1 Major Materials 1.2.2 Manufacturing Overview 1.3 Product List By Type 1.3.1 Tumor Antigens As Targets of Antibodies  1.3.2 Development of Antibodies for Clinical Purposes  1.3.3 Complement Dependent Cytotoxicity (CDC)  1.3.4 Signal Transduction Changes 1.4 End-Use List 1.4.1 Demand in Hospital  1.4.2 Demand in Clinic  1.4.3 Demand in Others 1.5 Global Market Overview 1.5.1 Global Market Size and Forecast, 2015-2025 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025 2 Global Production & Consumption by Geography 2.1 Global Production & Consumption 2.1.1 Global Production 2.1.2 Global Consumption 2.2 Geographic Production & Consumption 2.2.1 Production 2.2.1.1 Asia-Pacific 2.2.1.2 North America 2.2.1.3 South America 2.2.1.4 Europe 2.2.1.5 Middle East & Africa 2.2.2 Consumption 2.2.2.1 Asia-Pacific 2.2.2.2 North America 2.2.2.3 South America 2.2.2.4 Europe 2.2.2.5 Middle East & Africa 3 Major Manufacturers Introduction 3.1 Manufacturers Overview 3.2 Manufacturers List 3.2.1 Advaxis  Overview 3.2.1.1 Product Specifications 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.1.3 Recent Developments 3.2.1.4 Future Strategic Planning 3.2.2 Bind Therapeutics  Overview 3.2.2.1 Product Specifications 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.2.3 Recent Developments 3.2.2.4 Future Strategic Planning 3.2.3 Boehringer Ingelheim  Overview 3.2.3.1 Product Specifications 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.3.3 Recent Developments 3.2.3.4 Future Strategic Planning 3.2.4 Bristol Mayer Squibb  Overview 3.2.4.1 Product Specifications 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.4.3 Recent Developments 3.2.4.4 Future Strategic Planning 3.2.5 Celldex Therapeutics  Overview 3.2.5.1 Product Specifications 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.5.3 Recent Developments 3.2.5.4 Future Strategic Planning 3.2.6 Dendreon Corporation  Overview 3.2.6.1 Product Specifications 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.6.3 Recent Developments 3.2.6.4 Future Strategic Planning 3.2.7 Eli Lily  Overview 3.2.7.1 Product Specifications 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.7.3 Recent Developments 3.2.7.4 Future Strategic Planning 3.2.8 GalaxoSmithKline  Overview 3.2.8.1 Product Specifications 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.8.3 Recent Developments 3.2.8.4 Future Strategic Planning 3.2.9 Galena Biopharma  Overview 3.2.9.1 Product Specifications 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.9.3 Recent Developments 3.2.9.4 Future Strategic Planning 3.2.10 Genetech  Overview 3.2.10.1 Product Specifications 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.10.3 Recent Developments 3.2.10.4 Future Strategic Planning 3.2.11 ImmunoCellular Therapeutics  Overview 3.2.11.1 Product Specifications 3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.11.3 Recent Developments 3.2.11.4 Future Strategic Planning 3.2.12 ImmunoGen  Overview 3.2.12.1 Product Specifications 3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.12.3 Recent Developments 3.2.12.4 Future Strategic Planning 3.2.13 Inovio Pharmaceuticals  Overview 3.2.13.1 Product Specifications 3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.13.3 Recent Developments 3.2.13.4 Future Strategic Planning 3.2.14 Johnson & Johnson  Overview 3.2.14.1 Product Specifications 3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.14.3 Recent Developments 3.2.14.4 Future Strategic Planning 3.2.15 NeoStem Oncology  Overview 3.2.15.1 Product Specifications 3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.15.3 Recent Developments 3.2.15.4 Future Strategic Planning 3.2.16 NewLink Genetics  Overview 3.2.16.1 Product Specifications 3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.16.3 Recent Developments 3.2.16.4 Future Strategic Planning 3.2.17 Northwest Biotherapeutics  Overview 3.2.17.1 Product Specifications 3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.17.3 Recent Developments 3.2.17.4 Future Strategic Planning 3.2.18 Merck  Overview 3.2.18.1 Product Specifications 3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.18.3 Recent Developments 3.2.18.4 Future Strategic Planning 3.2.19 Novartis  Overview 3.2.19.1 Product Specifications 3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.19.3 Recent Developments 3.2.19.4 Future Strategic Planning 3.2.20 Peregrine Pharmaceuticals  Overview 3.2.20.1 Product Specifications 3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.20.3 Recent Developments 3.2.20.4 Future Strategic Planning 3.2.21 Pfizer  Overview 3.2.21.1 Product Specifications 3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.21.3 Recent Developments 3.2.21.4 Future Strategic Planning 3.2.22 Roche  Overview 3.2.22.1 Product Specifications 3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.22.3 Recent Developments 3.2.22.4 Future Strategic Planning 3.2.23 Sanofi  Overview 3.2.23.1 Product Specifications 3.2.23.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.23.3 Recent Developments 3.2.23.4 Future Strategic Planning 3.2.24 Seattle Genetics  Overview 3.2.24.1 Product Specifications 3.2.24.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.24.3 Recent Developments 3.2.24.4 Future Strategic Planning 3.2.25 Teva Overview 3.2.25.1 Product Specifications 3.2.25.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin) 3.2.25.3 Recent Developments 3.2.25.4 Future Strategic Planning 4 Market Competition Pattern 4.1 Market Size and Sketch 4.2 Company Market Share 4.2.1 Global Production by Major Manufacturers 4.2.2 Market Concentration Analysis 4.3 Market News and Trend 4.3.1 Merger & Acquisition 4.3.2 New Product Launch 5 Product Type Segment 5.1 Global Overview by Product Type Segment 5.2 Segment Subdivision by Product Type 5.2.1 Market in Tumor Antigens As Targets of Antibodies  5.2.1.1 Market Size 5.2.1.2 Situation & Development 5.2.2 Market in Development of Antibodies for Clinical Purposes  5.2.2.1 Market Size 5.2.2.2 Situation & Development 5.2.3 Market in Complement Dependent Cytotoxicity (CDC)  5.2.3.1 Market Size 5.2.3.2 Situation & Development 5.2.4 Market in Signal Transduction Changes 5.2.4.1 Market Size 5.2.4.2 Situation & Development 6 End-Use Segment 6.1 Global Overview by End-Use Segment 6.2 Segment Subdivision 6.2.1 Market in Hospital  6.2.1.1 Market Size 6.2.1.2 Situation & Development 6.2.2 Market in Clinic  6.2.2.1 Market Size 6.2.2.2 Situation & Development 6.2.3 Market in Others 6.2.3.1 Market Size 6.2.3.2 Situation & Development 7 Market Forecast & Trend 7.1 Regional Forecast 7.2 Consumption Forecast 7.2.1 Product Type Forecast 7.2.2 End-Use Forecast 7.3 Investment Trend 7.4 Consumption Trend 8 Price & Channel 8.1 Price and Cost 8.1.1 Price 8.1.2 Cost 8.2 Channel Segment 9 Market Drivers & Investment Environment 9.1 Market Drivers 9.2 Investment Environment 10 Research Conclusion

Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025 Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025 Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025 Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table Major Manufacturers Headquarters and Contact Information Table Major Manufacturers Capacity List in 2018 Table Advaxis  Overview List Table Cancer Targeted Therapy Business Operation of Advaxis  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Bind Therapeutics  Overview List Table Cancer Targeted Therapy Business Operation of Bind Therapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Boehringer Ingelheim  Overview List Table Cancer Targeted Therapy Business Operation of Boehringer Ingelheim  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Bristol Mayer Squibb  Overview List Table Cancer Targeted Therapy Business Operation of Bristol Mayer Squibb  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Celldex Therapeutics  Overview List Table Cancer Targeted Therapy Business Operation of Celldex Therapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Dendreon Corporation  Overview List Table Cancer Targeted Therapy Business Operation of Dendreon Corporation  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Eli Lily  Overview List Table Cancer Targeted Therapy Business Operation of Eli Lily  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table GalaxoSmithKline  Overview List Table Cancer Targeted Therapy Business Operation of GalaxoSmithKline  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Galena Biopharma  Overview List Table Cancer Targeted Therapy Business Operation of Galena Biopharma  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Genetech  Overview List Table Cancer Targeted Therapy Business Operation of Genetech  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table ImmunoCellular Therapeutics  Overview List Table Cancer Targeted Therapy Business Operation of ImmunoCellular Therapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table ImmunoGen  Overview List Table Cancer Targeted Therapy Business Operation of ImmunoGen  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Inovio Pharmaceuticals  Overview List Table Cancer Targeted Therapy Business Operation of Inovio Pharmaceuticals  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Johnson & Johnson  Overview List Table Cancer Targeted Therapy Business Operation of Johnson & Johnson  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table NeoStem Oncology  Overview List Table Cancer Targeted Therapy Business Operation of NeoStem Oncology  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table NewLink Genetics  Overview List Table Cancer Targeted Therapy Business Operation of NewLink Genetics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Northwest Biotherapeutics  Overview List Table Cancer Targeted Therapy Business Operation of Northwest Biotherapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Merck  Overview List Table Cancer Targeted Therapy Business Operation of Merck  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Novartis  Overview List Table Cancer Targeted Therapy Business Operation of Novartis  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Peregrine Pharmaceuticals  Overview List Table Cancer Targeted Therapy Business Operation of Peregrine Pharmaceuticals  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Pfizer  Overview List Table Cancer Targeted Therapy Business Operation of Pfizer  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Roche  Overview List Table Cancer Targeted Therapy Business Operation of Roche  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Sanofi  Overview List Table Cancer Targeted Therapy Business Operation of Sanofi  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Seattle Genetics  Overview List Table Cancer Targeted Therapy Business Operation of Seattle Genetics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Teva Overview List Table Cancer Targeted Therapy Business Operation of Teva (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin) Table Global Production Volume List by Manufacturers, 2015-2018, in Volume Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume Table Global Market Forecast by Region Segment 2019-2025, in Million USD Table Global Market Forecast by Region Segment 2019-2025, in Volume Table Global Market Amount by Product Type Segment 2019-2025, in Million USD Table Global Market Volume by Product Type Segment 2019-2025, in Volume Table Global Market Amount by End-Use Segment 2019-2025, in Million USD Table Global Market Volume by End-Use Segment 2019-2025, in VolumeFigure Cancer Targeted Therapy Picture List Figure Global Market Size and Forecast with Growth Rate, 2015-2025 Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD Figure Global Market Volume and Growth Rate, 2015-2018, in Volume Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD Figure North America Market Volume and Growth Rate, 2015-2018, in Volume Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD Figure Global Production Volume Share by Manufacturers in 2019, in Volume Figure Global Production Amount Share by Manufacturers in 2019, in Million USD Figure Global Market Amount and Growth Rate in Tumor Antigens As Targets of Antibodies , 2015-2018, in USD Million Figure Global Market Amount and Growth Rate in Tumor Antigens As Targets of Antibodies , 2015-2018, in Volume Figure Global Market Amount and Growth Rate in Development of Antibodies for Clinical Purposes , 2015-2018, in USD Million Figure Global Market Amount and Growth Rate in Development of Antibodies for Clinical Purposes , 2015-2018, in Volume Figure Global Market Amount and Growth Rate in Complement Dependent Cytotoxicity (CDC) , 2015-2018, in USD Million Figure Global Market Amount and Growth Rate in Complement Dependent Cytotoxicity (CDC) , 2015-2018, in Volume Figure Global Market Amount and Growth Rate in Signal Transduction Changes, 2015-2018, in USD Million Figure Global Market Amount and Growth Rate in Signal Transduction Changes, 2015-2018, in Volume Figure Global Market Amount and Growth Rate in Hospital , 2015-2018, in USD Million Figure Global Market Amount and Growth Rate in Hospital , 2015-2018, in Volume Figure Global Market Amount and Growth Rate in Clinic , 2015-2018, in USD Million Figure Global Market Amount and Growth Rate in Clinic , 2015-2018, in Volume Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million Figure Global Market Amount and Growth Rate in Others, 2015-2018, in Volume